Evidence map›Paper›PMID 39323909›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2024

Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation.

P Kreiner, E Eggenhofer, L Schneider, C Rejas, M Goetz, N Bogovic, S M Brunner, K Evert, H J Schlitt, E K Geissler and 1 more

Abstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Modeling ischemic-type biliary lesionFrontiers in bioengineering and biotechnology · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

P KreinerDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
E EggenhoferDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
L SchneiderDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
C RejasDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
M GoetzDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
N BogovicDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
S M BrunnerDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
K EvertDepartment of Pathology, University Hospital Regensburg, Regensburg, Germany.
H J SchlittDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
E K GeisslerDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.
H JungerDepartment of Surgery, University Hospital Regensburg, Regensburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biliary complications are still a major cause for morbidity and mortality after liver transplantation (LT). Ischemia/reperfusion injury (IRI) leads to disruption of the biliary epithelium. We introduce a novel model to study the effect of IRI on human cholangiocytes using extrahepatic cholangiocyte organoids (ECOs). Extrahepatic bile duct tissue was collected during LT at static cold storage and after reperfusion (n = 15); gallbladder tissue was used for controls (n = 5). ECOs (n = 9) were cultured from extrahepatic biliary tissue, with IRI induced in an atmosphere of 95% air (nitrogen), 1% O

Indexed as

Bile Ducts, ExtrahepaticLiver TransplantationOrganoidsReperfusion InjuryApoptosisCell ProliferationHumansMalecholangiocyte organoidscholangiopathyliver transplantorganoidsregenerative medicine

Identifiers

PMID39323909
PMCPMC11422091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.